-
2-cyano-4-pyridine carboxylic acid methyl ester
-
(3H-benzo[d]imidazol-4-yl)methanamine
-
1-(4-Aminophenyl)-4-(4-methoxyphenyl)piperazine
-
(R)-(-)-N-Boc-3-pyrrolidinol
-
Lonafanib, boceprevir
-
Methyl-6-o-triphenylmethyl-alpha-d-glucopyranoside
-
NALPHA-FMOC-L-SERINE TERT-BUTYL ESTER
-
4-Nitronaphthylamine
-
Intermediate of Dolutegravir
-
204512-90-3
-
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
-
LCZ696 interMediate
-
Benzofuran-6-carboxylic acid
-
4,5-Diphenyl-2-(N-ethyl-N-(2-hydroxyethyl)amino)oxazole
-
Des[1-(4,4-difluorocyclohexanecarboxamido)-1-phenylpropyl] Maraviroc
-
(1R,2R)-2-(3,4-difluorophenyl)cyclopropane carboxaMide
![(3H-benzo[d]imidazol-4-yl)methanamine](https://stcdn.activebiopharma.com/active/ABP026028.png)
![Des[1-(4,4-difluorocyclohexanecarboxamido)-1-phenylpropyl] Maraviroc](https://stcdn.activebiopharma.com/active/ABP026015.png)
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by Moldb.
浙公网安备 33010802003999号